Medscape September 12, 2023
Miriam E. Tucker

TOPLINE:

In an online survey of 605 people with diabetes who use insulin and continuous glucose monitors (CGMs), a majority expressed satisfaction with many aspects of the devices’ performance. However, significant proportions also reported concerns about accuracy under certain circumstances, and about skin problems.

METHODOLOGY:

Researchers did an online survey of 504 people with type 1 diabetes from the T1D Exchange and 101 with type 2 diabetes from the Dynata database.

TAKEAWAY:

  • The Dexcom G6 device was used by 60.7% of all current CGM users, including 69% of those with type 1 diabetes vs 12% with type 2 diabetes.

  • People with type 2 diabetes were more likely to use older Dexcom versions (G4/G5) (32%) or Abbott’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Patient / Consumer, Provider, Survey / Study, Technology, Trends, Wearables
Oura Ring Is ‘Like An Apple Product’ And Could Take Key Health Metric Mainstream
Wearable ultrasound sensor revolutionizes continuous blood pressure monitoring
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review

Share This Article